Skip to main content

New Drugs 2020

Tracking # 20-794989

$10.00

There are no ratings for this course

Learn more
CE Broker Reporting Reported automatically
Method Home Study

Course overview

RX and NP For drugs reviewed in detail, provide the FDA approved indication state the recommended dose and discuss the evidence supporting the drug approval and its potential role in therapy. For drugs reviewed in detail describe significant warnings and precautions. Provide 2-3 patient counseling tips for each. For the briefly summarized drugs in Table 2 state the generic brand names dosage form FDA approved indication and safety concerns if discussed. Briefly describe the new targeted therapies for the treatment of NSCLC e g how they work role in therapy. Technicians For drugs reviewed in detail provide the FDA approved indication state the recommended dose and discuss the evidence supporting the drug approval and its potential role in therapy. For drugs reviewed in detail, describe significant warnings and precautions. Provide 2-3 patient counseling tips for each. For the briefly summarized drugs in Table 2, state the generic brand names, dosage form FDA approved indication and safety concerns, if discussed. Briefly describe the new targeted therapies for the treatment of NSCLC e g how they work role in therapy.

Subject areas

This course counts toward the state boards and subject areas below.

Arkansas State Board of Nursing

Certified Nurse Practitioner

2h Practice-Focused Continuing Education

Clinical Nurse Specialist

2h Practice-Focused Continuing Education

Registered Nurse

2h Practice-Focused Continuing Education

Registered Nurse Practitioner

2h Practice-Focused Continuing Education

District of Columbia Board of Nursing

Nurse Practitioner

2h Pharmacology Component

Florida Board of Nursing

Advanced Practice Registered Nurse

2h General

Licensed Practical Nurse

2h General

Registered Nurse

2h General

Georgia Board of Nursing

Licensed Practical Nurse

2h General

Registered Professional Nurse

2h General

New Mexico Board of Nursing

Certified Nurse Practitioner

2h Continuing education related to pharmacology

Certified Registered Nurse Anesthetist

2h Continuing education related to pharmacology

Clinical Nurse Specialist

2h Continuing education related to pharmacology

Registered Nurse

2h Continuing education relevant to nursing practice

South Carolina Board of Nursing

Advanced Practice Registered Nurse

2h General

Licensed Practical Nurse

2h General

Registered Nurse

2h General

Disclosure statements

Dr. Chan reports no financial relationship with the manufacturer(s) or provider(s) of any commercial product(s) or service(s) that appear in this issue.